Global Antinuclear Antibody Test Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	139 Pages	TechNavio	June, 2024	INF19007007

Best Price Guarantee
Price	from $2,500
Length	139 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19007007

Global Antinuclear Antibody Test Market 2024-2028

The antinuclear antibody test market is forecasted to grow by USD 392 mn during 2023-2028, accelerating at a CAGR of 7.08% during the forecast period. The report on the antinuclear antibody test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for ana tests, rising government initiatives, and rising number of reagent rental agreements.

Technavio's antinuclear antibody test market is segmented as below:

By End-user

Hospitals
Clinical diagnostic laboratories

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing prevalence of autoimmune diseases as one of the prime reasons driving the antinuclear antibody test market growth during the next few years. Also, rising population and healthcare expenditure and increasing geriatric population will lead to sizable demand in the market.

The report on the antinuclear antibody test market covers the following areas:

Antinuclear antibody test market sizing
Antinuclear antibody test market forecast
Antinuclear antibody test market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antinuclear antibody test market vendors that include Abbott Laboratories, Abcam plc, Antibodies Inc., Bio Rad Laboratories Inc., BioVision Inc., Grifols SA, Immuno Concepts Ltd., Merck KGaA, Orgentec Diagnostika GmbH, Perkin Elmer Inc., Quidelortho Corp., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., Trinity Biotech Plc, Werfenlife SA, and ZEUS Scientific Inc.. Also, the antinuclear antibody test market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Antinuclear Antibody Test Market 2018 - 2022; Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.4 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 6.4 Clinical diagnostic laboratories - Market size and forecast 2023-2028; Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%); Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Customer Landscape: 7.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Chart on Market share by geography 2023-2028 (%); Data Table on Market share by geography 2023-2028 (%); 8.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 8.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 8.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 8.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 8.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 8.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 8.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 8.9 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 8.10 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 8.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 8.12 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 11.4 Antibodies Inc.; Antibodies Inc. - Overview; Antibodies Inc. - Product / Service; Antibodies Inc. - Key offerings; 11.5 BioVision Inc.; BioVision Inc. - Overview; BioVision Inc. - Product / Service; BioVision Inc. - Key offerings; 11.6 Grifols SA; Grifols SA - Overview; Grifols SA - Business segments; Grifols SA - Key news; Grifols SA - Key offerings; Grifols SA - Segment focus; 11.7 Immuno Concepts Ltd.; Immuno Concepts Ltd. - Overview; Immuno Concepts Ltd. - Product / Service; Immuno Concepts Ltd. - Key offerings; 11.8 Orgentec Diagnostika GmbH; Orgentec Diagnostika GmbH - Overview; Orgentec Diagnostika GmbH - Product / Service; Orgentec Diagnostika GmbH - Key offerings; 11.9 Perkin Elmer Inc.; Perkin Elmer Inc. - Overview; Perkin Elmer Inc. - Business segments; Perkin Elmer Inc. - Key news; Perkin Elmer Inc. - Key offerings; Perkin Elmer Inc. - Segment focus; 11.10 Quidelortho Corp.; Quidelortho Corp. - Overview; Quidelortho Corp. - Product / Service; Quidelortho Corp. - Key news; Quidelortho Corp. - Key offerings; 11.11 Werfenlife SA; Werfenlife SA - Overview; Werfenlife SA - Product / Service; Werfenlife SA - Key offerings; 11.12 ZEUS Scientific Inc.; ZEUS Scientific Inc. - Overview; ZEUS Scientific Inc. - Product / Service; ZEUS Scientific Inc. - Key offerings
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Parent Market; Exhibits10: Data Table on - Parent Market; Exhibits11: Market characteristics analysis; Exhibits12: Value Chain Analysis; Exhibits13: Offerings of companies included in the market definition; Exhibits14: Market segments; Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Historic Market Size - Data Table on Global Antinuclear Antibody Test Market 2018 - 2022 ($ million); Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by End-user ($ million); Exhibits43: Data Table on Market opportunity by End-user ($ million); Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits45: Chart on Market share by geography 2023-2028 (%); Exhibits46: Data Table on Market share by geography 2023-2028 (%); Exhibits47: Chart on Geographic comparison; Exhibits48: Data Table on Geographic comparison; Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits85: Market opportunity by geography ($ million); Exhibits86: Data Tables on Market opportunity by geography ($ million); Exhibits87: Impact of drivers and challenges in 2023 and 2028; Exhibits88: Overview on criticality of inputs and factors of differentiation; Exhibits89: Overview on factors of disruption; Exhibits90: Impact of key risks on business; Exhibits91: Companies covered; Exhibits92: Matrix on companies position and classification; Exhibits93: Abbott Laboratories - Overview; Exhibits94: Abbott Laboratories - Business segments; Exhibits95: Abbott Laboratories - Key news; Exhibits96: Abbott Laboratories - Key offerings; Exhibits97: Abbott Laboratories - Segment focus; Exhibits98: Antibodies Inc. - Overview; Exhibits99: Antibodies Inc. - Product / Service; Exhibits100: Antibodies Inc. - Key offerings; Exhibits101: BioVision Inc. - Overview; Exhibits102: BioVision Inc. - Product / Service; Exhibits103: BioVision Inc. - Key offerings; Exhibits104: Grifols SA - Overview; Exhibits105: Grifols SA - Business segments; Exhibits106: Grifols SA - Key news; Exhibits107: Grifols SA - Key offerings; Exhibits108: Grifols SA - Segment focus; Exhibits109: Immuno Concepts Ltd. - Overview; Exhibits110: Immuno Concepts Ltd. - Product / Service; Exhibits111: Immuno Concepts Ltd. - Key offerings; Exhibits112: Orgentec Diagnostika GmbH - Overview; Exhibits113: Orgentec Diagnostika GmbH - Product / Service; Exhibits114: Orgentec Diagnostika GmbH - Key offerings; Exhibits115: Perkin Elmer Inc. - Overview; Exhibits116: Perkin Elmer Inc. - Business segments; Exhibits117: Perkin Elmer Inc. - Key news; Exhibits118: Perkin Elmer Inc. - Key offerings; Exhibits119: Perkin Elmer Inc. - Segment focus; Exhibits120: Quidelortho Corp. - Overview; Exhibits121: Quidelortho Corp. - Product / Service; Exhibits122: Quidelortho Corp. - Key news; Exhibits123: Quidelortho Corp. - Key offerings; Exhibits124: Werfenlife SA - Overview; Exhibits125: Werfenlife SA - Product / Service; Exhibits126: Werfenlife SA - Key offerings; Exhibits127: ZEUS Scientific Inc. - Overview; Exhibits128: ZEUS Scientific Inc. - Product / Service; Exhibits129: ZEUS Scientific Inc. - Key offerings; Exhibits130: Inclusions checklist; Exhibits131: Exclusions checklist; Exhibits132: Currency conversion rates for US$; Exhibits133: Research methodology; Exhibits134: Information sources; Exhibits135: Data validation; Exhibits136: Validation techniques employed for market sizing; Exhibits137: Data synthesis; Exhibits138: 360 degree market analysis; Exhibits139: List of abbreviations